Western-Style Diet, pks Island-Carrying Escherichia coli, and Colorectal Cancer: Analyses From Two Large Prospective Cohort Studies
- PMID: 35760086
- PMCID: PMC9509428
- DOI: 10.1053/j.gastro.2022.06.054
Western-Style Diet, pks Island-Carrying Escherichia coli, and Colorectal Cancer: Analyses From Two Large Prospective Cohort Studies
Abstract
Background & aims: Evidence supports a carcinogenic role of Escherichia coli carrying the pks island that encodes enzymes for colibactin biosynthesis. We hypothesized that the association of the Western-style diet (rich in red and processed meat) with colorectal cancer incidence might be stronger for tumors containing higher amounts of pks+E coli.
Methods: Western diet score was calculated using food frequency questionnaire data obtained every 4 years during follow-up of 134,775 participants in 2 United States-wide prospective cohort studies. Using quantitative polymerase chain reaction, we measured pks+E coli DNA in 1175 tumors among 3200 incident colorectal cancer cases that had occurred during the follow-up. We used the 3200 cases and inverse probability weighting (to adjust for selection bias due to tissue availability), integrated in multivariable-adjusted duplication-method Cox proportional hazards regression analyses.
Results: The association of the Western diet score with colorectal cancer incidence was stronger for tumors containing higher levels of pks+E coli (Pheterogeneity = .014). Multivariable-adjusted hazard ratios (with 95% confidence interval) for the highest (vs lowest) tertile of the Western diet score were 3.45 (1.53-7.78) (Ptrend = 0.001) for pks+E coli-high tumors, 1.22 (0.57-2.63) for pks+E coli-low tumors, and 1.10 (0.85-1.42) for pks+E coli-negative tumors. The pks+E coli level was associated with lower disease stage but not with tumor location, microsatellite instability, or BRAF, KRAS, or PIK3CA mutations.
Conclusions: The Western-style diet is associated with a higher incidence of colorectal cancer containing abundant pks+E coli, supporting a potential link between diet, the intestinal microbiota, and colorectal carcinogenesis.
Keywords: Immunology; Microbiome; Molecular Pathological Epidemiology.
Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved.
Figures
Comment in
-
The Microbiome Modifies the Effect of Diet on Colorectal Cancer Incidence.Gastroenterology. 2022 Oct;163(4):812-813. doi: 10.1053/j.gastro.2022.07.066. Epub 2022 Aug 5. Gastroenterology. 2022. PMID: 35940254 No abstract available.
Similar articles
-
Dietary Patterns and Risk of Colorectal Cancer: Analysis by Tumor Location and Molecular Subtypes.Gastroenterology. 2017 Jun;152(8):1944-1953.e1. doi: 10.1053/j.gastro.2017.02.015. Epub 2017 Feb 27. Gastroenterology. 2017. PMID: 28249812 Free PMC article.
-
Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review.Mol Cancer. 2014 May 31;13:135. doi: 10.1186/1476-4598-13-135. Mol Cancer. 2014. PMID: 24885062 Free PMC article.
-
Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis.Gut. 2016 Dec;65(12):1973-1980. doi: 10.1136/gutjnl-2015-310101. Epub 2015 Aug 26. Gut. 2016. PMID: 26311717 Free PMC article.
-
Recommendations from the EGAPP Working Group: can testing of tumor tissue for mutations in EGFR pathway downstream effector genes in patients with metastatic colorectal cancer improve health outcomes by guiding decisions regarding anti-EGFR therapy?Genet Med. 2013 Jul;15(7):517-27. doi: 10.1038/gim.2012.184. Epub 2013 Feb 21. Genet Med. 2013. PMID: 23429431
-
The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis.Acta Oncol. 2014 Jul;53(7):852-64. doi: 10.3109/0284186X.2014.895036. Epub 2014 Mar 25. Acta Oncol. 2014. PMID: 24666267 Review.
Cited by
-
Escherichia coli on colorectal cancer: A two-edged sword.Microb Biotechnol. 2024 Oct;17(10):e70029. doi: 10.1111/1751-7915.70029. Microb Biotechnol. 2024. PMID: 39400440 Free PMC article. Review.
-
Contribution of PKS+ Escherichia coli to colon carcinogenesis through the inhibition of exosomal miR-885-5p.Heliyon. 2024 Sep 2;10(18):e37346. doi: 10.1016/j.heliyon.2024.e37346. eCollection 2024 Sep 30. Heliyon. 2024. PMID: 39315148 Free PMC article.
-
Nutrigenomic underpinnings of intestinal stem cells in inflammatory bowel disease and colorectal cancer development.Front Genet. 2024 Aug 30;15:1349717. doi: 10.3389/fgene.2024.1349717. eCollection 2024. Front Genet. 2024. PMID: 39280096 Free PMC article. Review.
-
Inverse Correlation between pks-Carrying Escherichia coli Abundance in Colorectal Cancer Liver Metastases and the Number of Organs Involved in Recurrence.Cancers (Basel). 2024 Aug 29;16(17):3003. doi: 10.3390/cancers16173003. Cancers (Basel). 2024. PMID: 39272861 Free PMC article.
-
Microbial genotoxin-elicited host DNA mutations related to mitochondrial dysfunction, a momentous contributor for colorectal carcinogenesis.mSystems. 2024 Sep 17;9(9):e0088724. doi: 10.1128/msystems.00887-24. Epub 2024 Aug 27. mSystems. 2024. PMID: 39189772 Free PMC article. Review.
References
-
- Nougayrede JP, Homburg S, Taieb F, et al. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 2006;313:848–51. - PubMed
-
- Barrett M, Hand CK, Shanahan F, et al. Mutagenesis by Microbe: the Role of the Microbiota in Shaping the Cancer Genome. Trends Cancer 2020;6:277–287. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R35 CA197735/CA/NCI NIH HHS/United States
- R01 CA118553/CA/NCI NIH HHS/United States
- P30 DK043351/DK/NIDDK NIH HHS/United States
- U01 CA167552/CA/NCI NIH HHS/United States
- R01 CA137178/CA/NCI NIH HHS/United States
- K24 DK098311/DK/NIDDK NIH HHS/United States
- UM1 CA186107/CA/NCI NIH HHS/United States
- R01 CA169141/CA/NCI NIH HHS/United States
- R35 CA253185/CA/NCI NIH HHS/United States
- P50 CA127003/CA/NCI NIH HHS/United States
- K07 CA190673/CA/NCI NIH HHS/United States
- P01 CA087969/CA/NCI NIH HHS/United States
- 27140/CRUK_/Cancer Research UK/United Kingdom
- P01 CA055075/CA/NCI NIH HHS/United States
- R01 CA151993/CA/NCI NIH HHS/United States
- K07 CA188126/CA/NCI NIH HHS/United States
- UM1 CA167552/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
